Open AccessEffects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study
Author(s) -
Robert T. Naismith,
Robert Bermel,
Christopher S. Coffey,
Andrew D. Goodman,
Janel Fedler,
Marianne Kearney,
Eric C. Klawiter,
Kunio Nakamura,
Sridar Narayanan,
Christopher Goebel,
Jon Yankey,
Elizabeth Klingner,
Robert J. Fox,
Sprint-Ms investigators
Publication year - 2021
Publication title -
neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.91
H-Index - 364
eISSN - 1526-632X
pISSN - 0028-3878
DOI - 10.1212/wnl.0000000000011314
Subject(s) - medicine , placebo , atrophy , multiple sclerosis , pathology , immunology , alternative medicine
To determine whether ibudilast has an effect on brain volume and new lesions in progressive forms of multiple sclerosis (MS).